Abstract: This invention relates to a method of treating hypertension and reducing serum lipase activity by dietary supplementation with conjugated linoleic acid. The method comprises administering a safe and effective amount of conjugated linoleic acid to a human. The conjugated linoleic acid may be provided in the form of a free fatty acid or chemical derivatives thereof in a pill, or as a component of a prepared food product.

Abstract: The present invention is related to a pharmaceutical combination of a glucocorticoid and a ?-cyclodextrin conjugated vitamin A derivative complex as well as a pharmaceutical composition comprising the same. The combination and the composition of the invention can be used for reducing or eliminating skin atrophy induced by treatment with glucocorticoids (GC). Also comprised is a method for reducing or eliminating skin atrophy induced by GC treatment. Furthermore the invention concerns a kit comprising a glucocorticoid and a ?-cyclodextrin conjugated vitamin A derivative complex.

Abstract: The present invention is related to compositions containing chitosan conjugated CLA (conjugated linoleic acid) and a chitosan conjugated Vitamin A or a ?-cyclodextrin conjugated vitamin A. The invention also concerns the preparation of the compositions. The compositions according to the invention can be used as topical and cosmetic compositions as well as pharmaceutical compositions for treatment of atopical dermatitis, psoriasis eczema as well as eczema of different origins and solar dermatitis.

Abstract: The present invention is related to compositions containing chitosan conjugated CLA (conjugated linoleic acid) and a chitosan conjugated Vitamin A or a &bgr;-cyclodextrin conjugated vitamin A. The invention also concerns the preparation of the compositions. The compositions according to the invention can be used as topical and cosmetic compositions as well as pharmaceutical compositions for treatment of atopical dermatitis, psoriasis eczema as well as eczema of different origins and solar dermatitis.

Abstract: This invention provides method of treatment and prophylaxis of both insulin (Type I) and non-insulin dependent (type II) diabetes mellitus, by administration of conjugated linoleic acid (CLA) in the form of pure isomers, selected isomer mixtures or non-selected isomer mixtures. The conjugated linoleic acids may be administered alone, or in combination with other diabetes therapeutic regimes.

Abstract: The invention relates to an arrangement for the administration of a fluid. The arrangement consists of a tube, preferably made of plastic, one end of which is executed with a cutting or tissue-displacing tip. The other end of the tube has a connection (1b) for an injection syringe or the like. Arranged in the tube is a rigid, elongated body so executed as to facilitate insertion of the tube into human tissue. The tube is sufficiently soft for it to be of essentially the same consistency as the surrounding tissue, in particular the subcutaneous tissue and musculator. It is also sealed at its tip and executed with a number of openings distributed over an area between the tip and the connection. The external surface of the tube is covered with a coating of titanium of sufficient thinness for the tube to retain its soft characteristics.

Abstract: An arrangement for the instillation of fluids in a urethra comprising a tube of rigidity and diameter to be capable of being introduced into the urethra. The invention is characterized in that the length of the tube is a fraction of the length of the urethra, or approximately one decimeter. Along most of its length the tube is executed with an inflatable sac with elastic walls. This exhibits straight cylindrical form in its uninflated state, and in its inflated state has a slim, conical form, the base of which is situated at the end of the tube, and the tip of which is attached to a flange near the other end of the tube. Near the flange the sac has a connection via which the sac can be inflated with and emptied of air. The arrangement also comprises a device adapted to suit the opening of the urethra, made of an elastic material, and anchored to the flange. The device is executed with a connection leading to a vacuum source.

Abstract: The present invention relates to an injection arrangement. This is characterized in that it comprises an injection needle (1) and a base plate (8). The needle (1) is curved so that at least one part of it exhibits a circular arc with a certain radius of curvature. The needle (1) is executed at one end with a solid, cutting point (2). The needle (1) has a central duct (3) which is closed in the area ahead of the tip (2) of the needle, and along the area in the form of a circular arc it has a number of openings (6) communicating with the duct (3). The base plate (8) has two curved ducts (11,12) passing through the plate (8) at an angle to one another and with the same radius of curvature as the needle (1). The base plate (8) also supports a cradle (13), to which the needle (1) is attached, which cradle is able to move in the base plate in such a way that the needle (1) is able to move in a normal plane to the plane of the base plate (8) in a reciprocating fashion about the center of the radius of curvature.